About EnsoData

EnsoData’s waveform AI platform provides clinicians, device manufacturers, and payors with AI-powered software solutions to identify, diagnose, and treatment sleep disordered patients. EnsoData’s first product, EnsoSleep, automates event detection and analysis of sleep studies, reducing the time required to score studies and providing clinicians with more time to focus on patient care.




Chris Fernandez | CEO & Co-Founder
Sam Rusk | President & Co-Founder
Nick Glattard | CTO & Co-Founder
Brock Hensen |COO

LinkedIn Facebook Twitter Website

Work for EnsoData

View Open Positions

In the News

Inspire Medical Systems Invests in AI Startup EnsoData HIT Consultant

Inspire Medical Systems has announced its investment in EnsoData, an artificial intelligence (AI) healthcare company helping clinicians uncover disease while patients sleep.

Read More
Forbes 30 Under 30 2021: Healthcare Forbes

Fernandez, Rusk and Glattard cofounded EnsoData, which uses AI to diagnose medical conditions. Its first product, which received FDA clearance in 2017, is aimed at sleep apnea. It's now used by more than 400 clinics across the U.S. to analyze sleep studies, helping more than 14,000 patients every month.

Read More
Episode #239: Chris Fernandez, EnsoData, Application of AI to Waveform Data Meb Faber Research

Episode #239: Chris Fernandez, EnsoData, “There Was One Particular Area That Felt Like It Was At Least 5 Years Behind…And That Was The Application Of AI To Waveform Data”

Read More
1 2

We’d love to hear from you.

Have an idea? Building a company? Seeking to partner with our portfolio companies? Please reach out, we’d love to hear from you.

Get In Touch